AR and prostate carcinoma: In this study we used two prostate cancer cell lines, DU145 and 22Rv1, that are respectively androgen receptor (AR) negative and positive, a receptor whose function is critical for prostate cancer progression [21, 22] and with which there is known cross-talk with the IGF-axis [23, 24].